PMC Fuels Breakthrough Pancreatic Cancer Treatment | Concord News

The Pan-Mass Challenge has raised over $1.1 billion since 1980, fueling groundbreaking cancer research at Dana-Farber and transforming patient care. It empowers top scientists, fosters global collaboration, and recently enabled a breakthrough drug that more than doubles survival rates for late-stage pancreatic cancer—targeting a once-untreatable mutation. Beyond science, the PMC offers profound emotional support, reminding patients they’re never alone in their fight. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0fc3eae20db1548e